MPLT

MapLight Therapeutics, Inc.

MPLT • NASDAQ

MapLight Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher A. Kroeger, with a market cap of $787.2M.

CEOChristopher A. Kroeger
Market Cap$787.2M
Biotechnology
Healthcare
Websitemaplightrx.com

Next Earnings

Upcoming earnings announcement for MapLight Therapeutics, Inc.

Date
Thursday, May 28, 2026 (in 2 months)
Timing
Before Market Open (3:30 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.84

Earnings History

Past 2 earnings reports for MapLight Therapeutics, Inc.

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Mar 26, 2026Q4 2025
-$2.47Est: -$0.92
-168.5%
-
—SEC10-K
Dec 4, 2025Q3 2025
-$37.18Est: -$1.36
-2633.8%
-
—SEC10-Q
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.